Network/NN
Graph/NN
Analysis/NN
of/IN
Gene-Gene/NN
Interactions/NNS
in/IN
Genome-Wide/NN
Association/NN
Study/NN
Data/NNS
./.
====================
Most/JJS
common/JJ
complex/NN
traits/VBZ
,/,
such/JJ
as/IN
obesity/NN
,/,
hypertension/NN
,/,
diabetes/VBZ
,/,
and/CC
cancers/NNS
,/,
are/VBP
known/VBN
to/TO
be/VB
associated/VBN
with/IN
multiple/JJ
genes/NNS
,/,
environmental/JJ
factors/NNS
,/,
and/CC
their/PRP$
epistasis/NN
./.
====================
Recently/RB
,/,
the/DT
development/NN
of/IN
advanced/JJ
genotyping/VBG
technologies/NNS
has/VBZ
allowed/VBN
us/PRP
to/TO
perform/VB
genome-wide/NN
association/NN
studies/NNS
(/(
GWASs/NNS
)/)
./.
====================
For/IN
detecting/VBG
the/DT
effects/NNS
of/IN
multiple/JJ
genes/NNS
on/IN
complex/NN
traits/VBZ
,/,
many/JJ
approaches/NNS
have/VBP
been/VBN
proposed/VBN
for/IN
GWASs/NNS
./.
====================
Multifactor/JJ
dimensionality/NN
reduction/NN
(/(
MDR/NN
)/)
is/VBZ
one/CD
of/IN
the/DT
powerful/JJ
and/CC
efficient/JJ
methods/NNS
for/IN
detecting/VBG
high-order/JJR
gene-gene/NN
(/(
GxG/NN
)/)
interactions/NNS
./.
====================
However/RB
,/,
the/DT
biological/JJ
interpretation/NN
of/IN
GxG/NN
interactions/NNS
identified/VBD
by/IN
MDR/NN
analysis/NN
is/VBZ
not/RB
easy/RB
./.
====================
In/IN
order/NN
to/TO
aid/VB
the/DT
interpretation/NN
of/IN
MDR/NN
results/NNS
,/,
we/PRP
propose/VBP
a/DT
network/NN
graph/NN
analysis/NN
to/TO
elucidate/VB
the/DT
meaning/VBG
of/IN
identified/VBN
GxG/NN
interactions/NNS
./.
====================
The/DT
proposed/JJ
network/NN
graph/NN
analysis/NN
consists/VBZ
of/IN
three/CD
steps/NNS
./.
====================
The/DT
first/JJ
step/NN
is/VBZ
for/IN
performing/VBG
GxG/NN
interaction/NN
analysis/NN
using/VBG
MDR/NN
analysis/NN
./.
====================
The/DT
second/JJ
step/NN
is/VBZ
to/TO
draw/VB
the/DT
network/NN
graph/NN
using/VBG
the/DT
MDR/NN
result/NN
./.
====================
The/DT
third/JJ
step/NN
is/VBZ
to/TO
provide/VB
biological/JJ
evidence/NN
of/IN
the/DT
identified/VBN
GxG/NN
interaction/NN
using/VBG
external/JJ
biological/JJ
databases/NNS
./.
====================
The/DT
proposed/JJ
method/NN
was/VBD
applied/VBN
to/TO
Korean/JJ
Association/NN
Resource/NN
(/(
KARE/NN
)/)
data/NNS
,/,
containing/VBG
8838/CD
individuals/NNS
with/IN
327,632/CD
single-nucleotide/JJ
polymorphisms/NNS
,/,
in/IN
order/NN
to/TO
perform/VB
GxG/NN
interaction/NN
analysis/NN
of/IN
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
./.
====================
Our/PRP$
network/NN
graph/NN
analysis/NN
successfully/RB
showed/VBD
that/IN
many/JJ
identified/VBN
GxG/NN
interactions/NNS
have/VBP
known/VBN
biological/JJ
evidence/NN
related/JJ
to/TO
BMI/NN
./.
====================
We/PRP
expect/VBP
that/DT
our/PRP$
network/NN
graph/NN
analysis/NN
will/MD
be/VB
helpful/JJ
to/TO
interpret/VB
the/DT
biological/JJ
meaning/VBG
of/IN
GxG/NN
interactions/NNS
./.
====================
In/IN
recent/JJ
years/NNS
,/,
a/DT
significant/JJ
advance/NN
of/IN
technology/NN
has/VBZ
been/VBN
achieved/VBN
in/IN
both/DT
genotyping/VBG
and/CC
computing/VBG
fields/NNS
,/,
which/WDT
has/VBZ
enabled/VBN
us/PRP
to/TO
perform/VB
large-scale/JJ
genome-wide/NN
association/NN
studies/NNS
(/(
GWASs/NNS
)/)
[/(
1/CD
,/,
2/CD
]/)
./.
====================
GWASs/NNS
have/VBP
provided/VBN
enormous/JJ
potential/JJ
in/IN
identifying/VBG
genetic/JJ
variants/NNS
for/IN
common/JJ
complex/NN
diseases/NNS
./.
====================
By/IN
GWASs/NNS
,/,
researchers/NNS
have/VBP
discovered/VBN
many/JJ
genetic/JJ
variants/NNS
that/DT
affect/VBP
common/JJ
complex/NN
traits/VBZ
,/,
such/JJ
as/IN
height/RB
,/,
type/NN
2/CD
diabetes/NNS
,/,
and/CC
blood/NN
pressure/NN
[/(
3-5/CD
]/)
./.
====================
In/IN
particular/JJ
,/,
the/DT
nature/NN
of/IN
obesity/NN
is/VBZ
related/JJ
with/IN
many/JJ
chronic/JJ
diseases/NNS
,/,
such/JJ
as/IN
type/NN
2/CD
diabetes/NNS
,/,
cardiovascular/JJ
disease/NN
,/,
and/CC
cancers/NNS
[/(
6-8/CD
]/)
./.
====================
In/IN
addition/NN
,/,
it/PRP
has/VBZ
been/VBN
found/VBN
that/IN
obesity/NN
may/MD
be/VB
caused/VBN
by/IN
multiple/JJ
genes/NNS
,/,
environmental/JJ
factors/NNS
,/,
and/CC
those/DT
interactions/NNS
[/(
9-11/CD
]/)
./.
====================
In/IN
order/NN
to/TO
identify/VB
the/DT
genes/NNS
associated/VBN
with/IN
obesity/NN
,/,
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
has/VBZ
been/VBN
commonly/RB
used/VBN
as/IN
an/DT
obesity-related/VBN
phenotype/NN
or/CC
trait/VBP
in/IN
GWASs/NNS
./.
====================
Many/JJ
studies/NNS
have/VBP
reported/VBN
that/IN
the/DT
genetic/JJ
variants/NNS
in/IN
FTO/NN
are/VBP
associated/VBN
with/IN
BMI/NN
[/(
12/CD
,/,
13/CD
]/)
./.
====================
Most/JJS
of/IN
these/DT
studies/NNS
have/VBP
used/VBN
the/DT
single/JJ
single-nucleotide/JJ
polymorphism/NN
(/(
SNP/NN
)/)
approach/NN
,/,
in/IN
which/WDT
each/DT
single/JJ
susceptible/JJ
locus/NN
is/VBZ
searched/VBN
in/IN
association/NN
with/IN
obesity/NN
./.
====================
The/DT
single/JJ
SNP/NN
approach/NN
has/VBZ
long/JJ
been/VBN
used/VBN
in/IN
detecting/VBG
genetic/JJ
traits/VBZ
,/,
and/CC
it/PRP
is/VBZ
especially/RB
optimal/JJ
for/IN
Mendelian/JJ
traits/VBZ
./.
====================
However/RB
,/,
complex/NN
traits/VBZ
are/VBP
well/RB
known/VBN
to/TO
be/VB
caused/VBN
by/IN
multiple/JJ
genetic/JJ
factors/NNS
as/IN
well/RB
as/IN
several/JJ
environmental/JJ
factors/NNS
and/CC
their/PRP$
interactions/NNS
./.
====================
Thus/RB
,/,
the/DT
single/JJ
SNP/NN
approach/NN
is/VBZ
not/RB
appropriate/JJ
for/IN
detecting/VBG
multiple/JJ
genetic/JJ
factors/NNS
affecting/VBG
common/JJ
complex/NN
polygenic/JJ
traits/VBZ
./.
====================
For/IN
the/DT
identification/NN
of/IN
multiple/JJ
and/CC
joint/NN
genetic/JJ
factors/NNS
associated/VBN
with/IN
complex/NN
traits/VBZ
,/,
the/DT
multifactor/JJ
dimensionality/NN
reduction/NN
(/(
MDR/NN
)/)
method/NN
has/VBZ
been/VBN
proposed/VBN
by/IN
Ritchie/NN
et/FW
al/JJ
./.
====================
[/(
14/CD
]/)
and/CC
applied/VBD
in/IN
detecting/VBG
gene-gene/NN
(/(
GxG/NN
)/)
interactions/NNS
[/(
15/CD
,/,
16/CD
]/)
./.
====================
However/RB
,/,
their/PRP$
approach/NN
can/MD
be/VB
applied/VBN
only/RB
to/TO
binary/VB
traits/VBZ
,/,
and/CC
the/DT
covariates/NNS
that/DT
may/MD
affect/VB
the/DT
phenotype/NN
can/MD
not/RB
be/VB
adjusted/VBN
./.
====================
In/IN
order/NN
to/TO
overcome/VB
these/DT
drawbacks/NNS
,/,
generalized/VBN
MDR/NN
(/(
GMDR/NN
)/)
analysis/NN
was/VBD
proposed/VBN
by/IN
Lou/JJ
et/FW
al/JJ
./.
====================
[/(
17/CD
]/)
,/,
in/IN
which/WDT
both/CC
binary/JJ
and/CC
quantitative/JJ
traits/VBZ
can/MD
be/VB
considered/VBN
phenotypes/NNS
while/IN
adjusting/VBG
for/IN
covariates/NNS
./.
====================
Although/IN
MDR/NN
and/CC
GMDR/NN
have/VBP
been/VBN
widely/RB
used/VBN
to/TO
detect/VB
GxG/NN
interactions/NNS
in/IN
genetic/JJ
association/NN
studies/NNS
,/,
their/PRP$
applications/NNS
have/VBP
been/VBN
mainly/RB
involved/VBN
in/IN
dealing/VBG
with/IN
candidate/NN
genes/NNS
or/CC
a/DT
small/JJ
set/NN
of/IN
genes/NNS
./.
====================
Since/IN
enormous/JJ
computational/JJ
complexity/NN
and/CC
high-speed/JJ
computing/VBG
resources/VBZ
are/VBP
required/VBN
in/IN
GWASs/NNS
,/,
neither/CC
MDR/NN
nor/CC
GMDR/NN
has/VBZ
been/VBN
successfully/RB
applied/VBN
to/TO
GWASs/NNS
./.
====================
In/IN
order/NN
to/TO
overcome/VB
these/DT
computational/JJ
limitations/NNS
,/,
we/PRP
previously/RB
proposed/VBN
an/DT
efficient/JJ
stepwise/JJ
approach/NN
to/TO
identify/VB
GxG/NN
interactions/NNS
for/IN
GWAS/NN
data/NNS
[/(
18/CD
]/)
using/VBG
cuGWAM/NN
,/,
a/DT
graphic/JJ
processing/NN
units/NNS
(/(
GPU/NN
)/)
-based/JJ
MDR/NN
program/NN
[/(
19/CD
]/)
./.
====================
However/RB
,/,
it/PRP
still/RB
remains/VBZ
a/DT
challenge/NN
to/TO
have/VB
a/DT
biological/JJ
interpretation/NN
of/IN
the/DT
identified/VBN
GxG/NN
interactions/NNS
./.
====================
In/IN
order/NN
to/TO
elucidate/VB
the/DT
identified/VBN
GxG/NN
interactions/NNS
,/,
we/PRP
propose/VBP
a/DT
network/NN
graph/NN
analysis/NN
./.
====================
Our/PRP$
network/NN
analysis/NN
method/NN
focuses/VBZ
not/RB
only/RB
on/IN
the/DT
biological/JJ
meaning/VBG
but/CC
also/RB
on/IN
the/DT
strength/NN
of/IN
interaction/NN
./.
====================
We/PRP
applied/VBD
our/PRP$
network/NN
graph/NN
approach/NN
to/TO
Korean/JJ
Association/NN
Resource/NN
(/(
KARE/NN
)/)
data/NNS
for/IN
GxG/NN
interactions/NNS
and/CC
its/PRP$
interpretation/NN
./.
====================
We/PRP
first/RB
performed/VBN
GMDR/NN
analysis/NN
for/IN
BMI/NN
./.
====================
Using/VBG
our/PRP$
network/NN
graph/NN
analysis/NN
,/,
we/PRP
then/RB
identified/VBD
several/JJ
GxG/NN
interactions/NNS
having/VBG
reasonable/JJ
biological/JJ
interpretation/NN
from/IN
the/DT
network/NN
graph/NN
using/VBG
public/JJ
biological/JJ
resources/NNS
./.
====================
The/DT
KARE/NN
data/NNS
====================
The/DT
KARE/NN
project/VB
,/,
established/VBN
as/IN
part/NN
of/IN
the/DT
Korean/JJ
Genome/NN
Epidemiology/JJ
Study/NN
(/(
KoGES/NN
)/)
in/IN
2001/CD
,/,
has/VBZ
started/VBN
to/TO
undertake/VB
a/DT
large-scale/JJ
genome-wide/NN
association/NN
analysis/NN
in/IN
Korean/JJ
population-based/JJ
cohort/NN
./.
====================
These/DT
cohorts/NNS
consist/VBP
of/IN
10,038/CD
participants/NNS
in/IN
the/DT
urban/JJ
Ansan/NN
(/(
n/NN
=/JJ
5,020/CD
)/)
and/CC
rural/JJ
Ansung/JJ
(/(
n/NN
=/JJ
5,018/CD
)/)
communities/VBZ
./.
====================
The/DT
objective/NN
of/IN
the/DT
KARE/NN
project/VB
is/VBZ
to/TO
identify/VB
genetic/JJ
factors/NNS
of/IN
several/JJ
clinical/JJ
traits/NNS
and/CC
lifestyle-related/JJ
diseases/NNS
by/IN
GWAS/NN
,/,
based/VBN
on/IN
population-based/JJ
cohorts/NNS
./.
====================
In/IN
this/DT
analysis/NN
,/,
we/PRP
focused/VBD
on/IN
BMI/NN
,/,
one/CD
of/IN
more/RBR
than/IN
260/CD
lifestyle-related/JJ
traits/VBZ
./.
====================
DNA/NN
samples/NNS
were/VBD
isolated/VBN
from/IN
the/DT
peripheral/JJ
blood/NN
of/IN
all/DT
participants/NNS
and/CC
were/VBD
genotyped/VBN
with/IN
Affymetrix/JJ
Genome-Wide/NN
Human/JJ
SNP/NN
array/NN
5.0/CD
(/(
Affymetrix/JJ
,/,
Rockville/NNP
,/,
MD/NN
,/,
USA/NNP
)/)
./.
====================
Genotypes/NNS
were/VBD
called/VBN
using/VBG
Bayesian/JJ
Robust/NNP
Linear/JJ
Modeling/JJ
using/VBG
the/DT
Mahalanobis/NN
distance/NN
(/(
BRLMM/NN
)/)
algorithm/NN
[/(
20/CD
]/)
./.
====================
We/PRP
performed/VBD
a/DT
quality/NN
control/NN
process/NN
for/IN
the/DT
sample/NN
and/CC
genotype/NN
as/IN
previously/RB
described/VBN
in/IN
Cho/NN
et/FW
al/JJ
./.
====================
[/(
2/CD
]/)
./.
====================
In/IN
order/NN
to/TO
increase/VB
the/DT
coverage/NN
of/IN
common/JJ
variants/NNS
and/CC
capture/NN
additional/JJ
association/NN
signals/NNS
,/,
we/PRP
performed/VBD
SNP/NN
imputation/NN
with/IN
PLINK/NN
using/VBG
the/DT
Japanese/Chinese/JJ
(/(
JPT/CHB/NN
)/)
component/NN
of/IN
HapMap/NN
as/IN
the/DT
reference/NN
./.
====================
After/IN
sample/NN
and/CC
genotype/NN
quality/NN
controls/NNS
,/,
327,872/CD
SNPs/NNS
for/IN
8,842/CD
individuals/NNS
were/VBD
available/JJ
in/IN
the/DT
KARE/NN
data/NNS
./.
====================
We/PRP
applied/VBD
our/PRP$
proposed/JJ
regularization/NN
method/NN
to/TO
Korean/JJ
genome-wide/NN
data/NNS
./.
====================
Network/NN
graph/NN
analysis/NN
====================
GMDR/NN
analysis/NN
step/NN
====================
GWAS/NN
datasets/NNS
usually/RB
have/VBP
enormous/JJ
number/NN
of/IN
markers/NNS
,/,
which/WDT
causes/VBZ
a/DT
severe/JJ
computational/JJ
burden/NN
./.
====================
In/IN
order/NN
to/TO
deal/JJ
with/IN
this/DT
computation/NN
problem/NN
,/,
the/DT
single/JJ
SNP/NN
association/NN
test/NN
with/IN
covariate/JJ
adjustment/JJ
is/VBZ
performed/VBN
to/TO
all/DT
SNPs/NNS
in/IN
a/DT
dataset/NN
./.
====================
This/DT
step/NN
can/MD
be/VB
achieved/VBN
via/IN
several/JJ
toolkits/NNS
that/DT
support/VBP
regression/NN
analysis/NN
,/,
such/JJ
as/IN
PLINK/NN
./.
====================
Filtering/VBG
by/IN
specific/JJ
criteria/NNS
,/,
such/JJ
as/IN
p-value/JJ
,/,
is/VBZ
subsequently/RB
performed/VBN
in/IN
order/NN
to/TO
reduce/VB
the/DT
number/NN
of/IN
SNPs/NNS
./.
====================
With/IN
the/DT
selected/VBN
SNPs/NNS
from/IN
the/DT
single/JJ
SNP/NN
association/NN
analysis/NN
,/,
exhaustive/JJ
two-way/NN
GMDR/NN
analysis/NN
is/VBZ
then/RB
applied/VBD
./.
====================
However/RB
,/,
general/JJ
toolkits/NNS
supporting/VBG
GMDR/NN
analysis/NN
can/MD
only/RB
handle/NN
hundreds/VBZ
of/IN
SNPs/NNS
./.
====================
Although/IN
the/DT
number/NN
of/IN
SNPs/NNS
in/IN
this/DT
step/NN
can/MD
be/VB
reduced/VBN
by/IN
giving/VBG
more/RBR
stringent/JJ
criteria/NNS
,/,
it/PRP
may/MD
ignore/VB
the/DT
SNPs/NNS
having/VBG
marginally/RB
less/RBR
significant/JJ
effects/NNS
./.
====================
In/IN
addition/NN
,/,
a/DT
scheme/NN
to/TO
reduce/VB
overfitting/VBG
,/,
such/JJ
as/IN
cross-validation/NN
,/,
requires/VBZ
increased/VBD
linear/JJ
computation/NN
time/NN
./.
====================
In/IN
order/NN
to/TO
solve/VB
this/DT
problem/NN
,/,
faster/JJR
toolkits/VBZ
are/VBP
recommended/VBN
,/,
such/JJ
as/IN
GPU-based/JJ
GMDR/NN
analysis/NN
toolkits/VBZ
like/IN
cuGWAM/NN
[/(
19/CD
]/)
./.
====================
Since/IN
the/DT
number/NN
of/IN
combinations/NNS
in/IN
GMDR/NN
analysis/NN
is/VBZ
usually/RB
very/RB
large/JJ
,/,
all/DT
results/NNS
of/IN
GMDR/NN
can/MD
not/RB
be/VB
stored/VBN
./.
====================
Thus/RB
,/,
a/DT
criterion/JJ
is/VBZ
needed/VBN
to/TO
store/VB
the/DT
specific/JJ
interactions/NNS
satisfying/JJ
the/DT
criterion/NN
,/,
such/JJ
as/IN
balanced/JJ
accuracy/NN
(/(
BA/NN
)/)
./.
====================
Network/NN
graph/NN
construction/NN
====================
Network/NN
graph/NN
is/VBZ
often/RB
used/VBN
to/TO
visualize/VB
multiple/JJ
sets/NNS
of/IN
interactions/NNS
./.
====================
It/PRP
consists/VBZ
of/IN
nodes/NNS
and/CC
edges/NNS
connecting/VBG
two/CD
nodes/NNS
./.
====================
For/IN
simplicity/NN
of/IN
representation/NN
,/,
we/PRP
focus/VBP
on/IN
two-way/NN
interactions/NNS
./.
====================
Since/IN
the/DT
two-way/JJ
interaction/NN
is/VBZ
for/IN
the/DT
relationship/NN
between/IN
two/CD
variables/NNS
,/,
it/PRP
can/MD
be/VB
easily/RB
represented/VBN
as/IN
a/DT
graph/JJ
that/DT
contains/VBZ
two/CD
nodes/NNS
representing/VBG
two/CD
variables/NNS
of/IN
interaction/NN
and/CC
an/DT
edge/NN
corresponding/VBG
to/TO
the/DT
interaction/NN
./.
====================
According/VBG
to/TO
this/DT
scheme/NN
,/,
all/DT
interactions/NNS
identified/VBD
by/IN
GMDR/NN
analysis/NN
can/MD
be/VB
visualized/VBN
in/IN
the/DT
network/NN
graph/NN
./.
====================
However/RB
,/,
this/DT
scheme/NN
can/MD
cause/VB
too/RB
complex/NN
a/DT
graph/JJ
structure/NN
when/WRB
the/DT
number/NN
of/IN
interactions/NNS
is/VBZ
large/JJ
./.
====================
Thus/RB
,/,
it/PRP
is/VBZ
recommended/VBN
to/TO
select/VB
a/DT
certain/JJ
number/NN
of/IN
possible/JJ
interactions/NNS
in/IN
the/DT
network/NN
graph/NN
to/TO
reduce/VB
the/DT
complexity/NN
of/IN
the/DT
network/NN
graph/NN
./.
====================
Alternatively/RB
,/,
the/DT
complexity/NN
of/IN
the/DT
network/NN
graph/NN
can/MD
be/VB
reduced/VBN
by/IN
gene/NN
mapping/NN
information/NN
./.
====================
Since/IN
many/JJ
SNPs/NNS
are/VBP
placed/VBN
in/IN
a/DT
gene/NN
or/CC
adjacent/JJ
to/TO
a/DT
gene/NN
,/,
it/PRP
is/VBZ
possible/JJ
to/TO
annotate/VB
multiple/JJ
SNPs/NNS
into/IN
a/DT
single/JJ
node/NN
of/IN
a/DT
gene/NN
according/VBG
to/TO
their/PRP$
position/NN
./.
====================
However/RB
,/,
this/DT
approach/NN
requires/VBZ
a/DT
delicate/JJ
mapping/NN
process/NN
./.
====================
In/IN
addition/NN
,/,
the/DT
network/NN
graph/NN
can/MD
represent/VB
the/DT
strength/NN
of/IN
the/DT
interaction/NN
by/IN
the/DT
thickness/JJ
of/IN
the/DT
edge-that/NN
is/VBZ
,/,
the/DT
higher/JJR
the/DT
number/NN
of/IN
interactions/NNS
between/IN
two/CD
nodes/NNS
,/,
the/DT
thicker/NN
the/DT
edge/NN
becomes/VBZ
./.
====================
Network/NN
graph/NN
analysis/NN
====================
It/PRP
is/VBZ
important/JJ
to/TO
derive/VB
a/DT
reasonable/JJ
biological/JJ
interpretation/NN
of/IN
identified/VBN
GxG/NN
interactions/NNS
./.
====================
Here/RB
,/,
we/PRP
propose/VBP
a/DT
network/NN
graph/NN
analysis/NN
step/NN
to/TO
aid/VB
the/DT
biological/JJ
interpretation/NN
of/IN
the/DT
identified/VBN
GxG/NN
interaction/NN
by/IN
using/VBG
existing/VBG
biological/JJ
resources/NNS
./.
====================
In/IN
other/JJ
words/NNS
,/,
the/DT
goal/NN
of/IN
this/DT
step/NN
is/VBZ
to/TO
find/VB
known/VBN
biological/JJ
evidence/NN
that/IN
supports/VBZ
the/DT
identified/VBN
GxG/NN
interactions/NNS
./.
====================
Resources/NNS
used/VBN
in/IN
this/DT
step/NN
consist/VBP
of/IN
either/CC
a/DT
pair/NN
of/IN
a/DT
marker/NN
and/CC
target/NN
or/CC
two/CD
related/JJ
markers/NNS
,/,
where/WRB
a/DT
marker/NN
corresponds/VBZ
to/TO
a/DT
gene/NN
or/CC
SNP/NN
and/CC
a/DT
target/NN
represents/VBZ
a/DT
biologically/RB
proven/VBN
target/NN
related/JJ
with/IN
a/DT
marker/NN
./.
====================
From/IN
a/DT
resource/NN
with/IN
marker/NN
and/CC
target/NN
information/NN
,/,
such/JJ
as/IN
HuGENet/JJ
[/(
21/CD
]/)
,/,
miRBase/NN
[/(
22/CD
]/)
,/,
and/CC
is-rSNP/NN
[/(
23/CD
]/)
,/,
we/PRP
simply/RB
assume/VB
that/DT
there/EX
is/VBZ
biological/JJ
evidence/NN
if/IN
two/CD
SNPs/NNS
within/IN
an/DT
interaction/NN
share/VBP
the/DT
same/JJ
biological/JJ
target/NN
defined/VBN
in/IN
the/DT
biological/JJ
resource/NN
./.
====================
For/IN
resources/VBZ
,/,
such/JJ
as/IN
COXPRESdb/NN
[/(
24/CD
]/)
,/,
having/VBG
information/NN
about/IN
the/DT
correlation/NN
among/IN
genes/NNS
,/,
we/PRP
assume/VBP
that/DT
all/DT
correlated/VBD
genes/NNS
in/IN
these/DT
resources/NNS
have/VBP
biological/JJ
interactions/NNS
./.
====================
Although/IN
this/DT
is/VBZ
a/DT
naïve/JJ
assumption/NN
,/,
the/DT
use/NN
of/IN
these/DT
resources/NNS
is/VBZ
mainly/RB
to/TO
support/VB
the/DT
interactions/NNS
identified/VBD
by/IN
GMDR/NN
analysis/NN
./.
====================
Note/RB
that/DT
many/JJ
known/JJ
biological/JJ
resources/NNS
have/VBP
their/PRP$
own/JJ
unique/JJ
data/NNS
structures/NNS
that/DT
differ/VBP
from/IN
each/DT
other/JJ
./.
====================
Consequently/RB
,/,
the/DT
integration/NN
of/IN
multiple/JJ
resources/VBZ
is/VBZ
recommended/VBN
in/IN
order/NN
to/TO
provide/VB
further/JJ
biological/JJ
evidence/NN
for/IN
a/DT
given/VBN
GxG/NN
interaction/NN
./.
====================
In/IN
our/PRP$
GMDR/NN
analysis/NN
using/VBG
KARE/NN
data/NNS
,/,
we/PRP
first/RB
performed/VBN
the/DT
single/JJ
SNP/NN
association/NN
test/NN
via/IN
PLINK/NN
(/(
http/NN
:/:
//pngu.mgh.harvard.edu/~purcell/plink//JJ
)/)
using/VBG
a/DT
linear/JJ
regression/NN
model/NN
with/IN
covariate/JJ
adjustment/JJ
of/IN
age/NN
,/,
area/NN
,/,
and/CC
sex/NN
./.
====================
We/PRP
used/VBD
the/DT
p-value/JJ
from/IN
linear/JJ
regression/NN
as/IN
a/DT
criterion/JJ
of/IN
screening/VBG
and/CC
used/VBN
a/DT
p-value/JJ
threshold/RB
of/IN
3/CD
×/NN
10-1/CD
for/IN
the/DT
screening/NN
process/NN
;/:
101,837/CD
SNPs/NNS
were/VBD
carried/VBN
out/RP
after/IN
the/DT
screening/NN
process/NN
,/,
as/IN
a/DT
result/NN
of/IN
the/DT
single/JJ
SNP/NN
association/NN
test/NN
./.
====================
The/DT
top/NN
10/CD
SNPs/NNS
with/IN
the/DT
smallest/JJS
p-values/NNS
are/VBP
listed/VBN
in/IN
Table/JJ
1/CD
./.
====================
The/DT
GMDR/NN
analysis/NN
was/VBD
then/RB
performed/VBN
using/VBG
our/PRP$
GPU-based/JJ
software/RB
,/,
cuGWAM/NN
[/(
19/CD
]/)
,/,
in/IN
order/NN
to/TO
evaluate/VB
all/DT
possible/JJ
two-way/NN
interactions/NNS
and/CC
used/VBN
a/DT
10-fold/JJ
cross-validation/NN
scheme/NN
,/,
with/IN
covariate/JJ
adjustment/JJ
of/IN
age/NN
,/,
area/NN
,/,
and/CC
sex/NN
./.
====================
An/DT
exhaustive/JJ
search/VBP
for/IN
two-way/JJ
interactions/NNS
from/IN
the/DT
selected/VBN
SNPs/NNS
took/VBD
19/CD
h/NN
on/IN
the/DT
GPU/NN
system/NN
with/IN
three/CD
GTX285/NN
graphic/JJ
cards/NNS
./.
====================
In/IN
this/DT
step/NN
,/,
a/DT
total/JJ
of/IN
51,853,363,660/CD
possible/JJ
two-way/NN
interaction/NN
models/NNS
were/VBD
evaluated/VBN
./.
====================
In/IN
GMDR/NN
analysis/NN
,/,
10-fold/JJ
cross-validation/NN
was/VBD
used/VBN
./.
====================
For/IN
each/DT
cross-validation/NN
set/NN
,/,
the/DT
top/NN
10,000/CD
interactions/NNS
with/IN
the/DT
highest/JJS
test/NN
BAs/NNS
were/VBD
selected/VBN
,/,
where/WRB
BA/NN
is/VBZ
defined/VBN
as/IN
the/DT
arithmetic/JJ
mean/JJ
of/IN
sensitivity/NN
and/CC
specificity/NN
[/(
25/CD
]/)
./.
====================
We/PRP
then/RB
calculated/VBN
cross-validation/NN
consistency/NN
(/(
CVC/NN
)/)
,/,
which/WDT
represents/VBZ
how/WRB
many/JJ
times/NNS
the/DT
same/JJ
two-way/RB
interaction/NN
is/VBZ
selected/VBN
out/IN
of/IN
10/CD
cross-validation/NN
sets/NNS
./.
====================
Finally/RB
,/,
we/PRP
performed/VBD
a/DT
screening/NN
step/NN
for/IN
every/RB
pair/NN
of/IN
interactions/NNS
achieved/VBD
from/IN
GMDR/NN
analysis/NN
that/IN
satisfied/JJ
the/DT
two/CD
criteria/NNS
,/,
CVC/NN
≥/CD
9/CD
and/CC
test/VB
BA/NN
≥/CD
0.5/CD
./.
====================
Finally/RB
,/,
we/PRP
found/VBD
524/CD
two-way/NN
interactions/NNS
under/IN
these/DT
screening/NN
criteria/NNS
./.
====================
Among/IN
these/DT
interactions/NNS
,/,
127/CD
are/VBP
from/IN
genes/NNS
that/WDT
are/VBP
known/VBN
to/TO
be/VB
associated/VBN
with/IN
obesity/NN
and/CC
are/VBP
summarized/VBN
in/IN
Table/JJ
2/CD
./.
====================
Among/IN
these/DT
interactions/NNS
,/,
five/CD
genes-FTO/NN
,/,
CBARA1/NN
,/,
CHUK/NN
,/,
SLIT3/NN
,/,
and/CC
NRXN3-and/NN
59/CD
SNPs/NNS
have/VBP
been/VBN
reported/VBN
in/IN
previous/JJ
studies/NNS
[/(
15/CD
,/,
16/CD
,/,
26-29/CD
]/)
./.
====================
Visualization/NN
of/IN
these/DT
524/CD
two-way/NN
interactions/NNS
into/IN
a/DT
network/NN
graph/NN
was/VBD
then/RB
made/VBD
after/IN
annotating/VBG
SNPs/NNS
to/TO
the/DT
genes/NNS
./.
====================
We/PRP
used/VBD
Gephi/NN
(/(
https/NNS
:/:
//gephi.org/JJ
)/)
as/IN
a/DT
visualization/NN
tool/NN
./.
====================
Gene/NN
annotation/NN
was/VBD
performed/VBN
according/VBG
to/TO
the/DT
hg18/NN
human/JJ
genome/NN
reference/VBP
and/CC
dbSNP/NN
129/CD
./.
====================
These/DT
524/CD
twoway/NN
interactions/NNS
are/VBP
displayed/VBN
in/IN
the/DT
network/NN
graph/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Each/DT
node/NN
represents/VBZ
either/CC
an/DT
SNP/NN
or/CC
gene/NN
./.
====================
If/IN
a/DT
SNP/NN
is/VBZ
annotated/VBN
to/TO
a/DT
known/JJ
gene/NN
,/,
then/RB
it/PRP
is/VBZ
denoted/VBN
by/IN
the/DT
gene/NN
name/NN
./.
====================
The/DT
number/NN
of/IN
interactions/NNS
between/IN
nodes/NNS
was/VBD
represented/VBN
as/IN
the/DT
thickness/NN
of/IN
the/DT
edge/NN
./.
====================
For/IN
example/NN
,/,
node/NN
FTO/NN
has/VBZ
a/DT
very/RB
thick/JJ
edge/NN
with/IN
node/NN
NT5C2/NN
./.
====================
Conversely/RB
,/,
some/DT
nodes/NNS
have/VBP
a/DT
large/JJ
number/NN
of/IN
nodes/NNS
that/DT
are/VBP
connected/VBN
with/IN
it/PRP
./.
====================
We/PRP
call/JJ
these/DT
nodes/NNS
hub/NN
nodes/NNS
or/CC
hub/JJ
SNPs/NNS
./.
====================
Hub/NN
nodes/NNS
are/VBP
represented/VBN
by/IN
a/DT
gray/JJ
background/NN
color/JJ
./.
====================
We/PRP
investigated/VBD
which/WDT
SNPs/NNS
that/DT
were/VBD
included/VBN
in/IN
the/DT
524/CD
two-way/RB
interactions/NNS
are/VBP
related/JJ
with/IN
obesity/NN
using/VBG
DAVID/NN
[/(
30/CD
]/)
,/,
a/DT
comprehensive/JJ
set/NN
of/IN
functional/JJ
annotation/NN
tools/NNS
./.
====================
As/IN
a/DT
result/NN
,/,
we/PRP
detected/VBD
six/CD
genes-NDUFA8/NN
,/,
NDUFB8/NN
,/,
NDUFC2/NN
,/,
NDUFS2/NN
,/,
COX5A/NN
,/,
and/CC
ATP6V1B2/NN
./.
====================
The/DT
role/NN
of/IN
these/DT
genes/NNS
in/IN
the/DT
metabolism/NN
pathway/NN
is/VBZ
related/JJ
to/TO
oxidative/JJ
phosphorylation/NN
,/,
which/WDT
plays/VBZ
an/DT
important/JJ
role/NN
of/IN
hepatic/JJ
mitochondrial/JJ
function/NN
in/IN
the/DT
development/NN
of/IN
obesity/NN
[/(
31/CD
]/)
./.
====================
Among/IN
the/DT
524/CD
two-way/NN
interactions/NNS
,/,
some/DT
SNPs/NNS
might/MD
have/VB
weak/JJ
main/JJ
effects/NNS
but/CC
have/VBP
strong/JJ
interactions/NNS
with/IN
other/JJ
SNPs/NNS
./.
====================
Table/JJ
3/CD
shows/VBZ
the/DT
SNPs/NNS
from/IN
hub/JJ
genes/NNS
that/WDT
show/VBP
significant/JJ
two-way/NN
interactions/NNS
with/IN
other/JJ
SNPs/NNS
but/CC
have/VBP
weak/JJ
marginal/JJ
effects/NNS
in/IN
the/DT
single/JJ
SNP/NN
analysis/NN
./.
====================
For/IN
the/DT
network/NN
graph/NN
analysis/NN
,/,
four/CD
public/JJ
databases/NNS
(/(
HuGENet/NNP
[/(
21/CD
]/)
,/,
COXPRESdb/NN
[/(
24/CD
]/)
,/,
miRBase/NN
[/(
22/CD
]/)
,/,
and/CC
isrSNP/NN
[/(
23/CD
]/)
)/)
were/VBD
collected/VBN
and/CC
used/VBN
to/TO
investigate/VB
the/DT
biological/JJ
relationship/NN
between/IN
two/CD
SNPs/NNS
with/IN
an/DT
interaction/NN
./.
====================
A/DT
short/JJ
summary/NN
of/IN
each/DT
database/NN
is/VBZ
given/VBN
in/IN
Table/JJ
4/CD
./.
====================
All/DT
databases/NNS
used/VBN
in/IN
this/DT
study/NN
were/VBD
converted/VBN
from/IN
the/DT
original/JJ
bulk/NN
to/TO
a/DT
database/NN
table/JJ
with/IN
automated/JJ
script/NN
for/IN
the/DT
integrated/JJ
investigation/NN
./.
====================
The/DT
script/NN
for/IN
this/DT
conversion/NN
can/MD
be/VB
provided/VBN
upon/IN
request/VBP
./.
====================
In/IN
order/NN
to/TO
improve/VB
the/DT
biological/JJ
relevance/NN
of/IN
the/DT
interpretation/NN
,/,
we/PRP
excluded/VBD
all/DT
interactions/NNS
having/VBG
linkage/NN
disequilibrium/NN
(/(
LD/NN
)/)
between/IN
two/CD
SNPs/NNS
./.
====================
One/CD
of/IN
the/DT
results/NNS
of/IN
the/DT
network/NN
graph/NN
analysis/NN
is/VBZ
given/VBN
in/IN
Fig/NN
./.
====================
2/CD
./.
====================
We/PRP
identified/VBD
at/IN
least/JJS
one/CD
line/NN
of/IN
biological/JJ
evidence/NN
among/IN
26/CD
%/NN
of/IN
the/DT
524/CD
GxG/NN
interactions/NNS
./.
====================
In/IN
order/NN
to/TO
investigate/VB
the/DT
relationship/NN
between/IN
CVC/NN
and/CC
the/DT
rate/NN
of/IN
biological/JJ
evidence/NN
,/,
we/PRP
performed/VBD
an/DT
additional/JJ
network/NN
analysis/NN
using/VBG
1,838/NN
interactions/NNS
(/(
CVC/NN
≥/CD
7/CD
)/)
and/CC
found/VBD
out/IN
that/DT
there/EX
was/VBD
a/DT
strong/JJ
relationship/NN
between/IN
CVC/NN
of/IN
the/DT
GMDR/NN
analysis/NN
and/CC
the/DT
presence/NN
of/IN
known/JJ
biological/JJ
evidence/NN
./.
====================
As/IN
shown/VBN
in/IN
Table/JJ
5/CD
,/,
the/DT
proportion/NN
of/IN
interactions/NNS
having/VBG
a/DT
known/JJ
biological/JJ
interaction/NN
was/VBD
significantly/RB
higher/JJR
when/WRB
CVC/NN
=/JJ
10/CD
than/IN
when/WRB
7/CD
≤/CD
CVC/NN
</JJR
10/CD
(/(
39/CD
%/NN
vs./CC
17/CD
%/NN
on/IN
average/NN
)/)
./.
====================
In/IN
addition/NN
,/,
from/IN
the/DT
network/NN
analysis/NN
of/IN
179/CD
interactions/NNS
having/VBG
CVC/NN
=/JJ
10/CD
,/,
69/CD
interactions/NNS
showed/VBD
biological/JJ
evidence/NN
and/CC
30/CD
(/(
43/CD
%/NN
of/IN
69/CD
)/)
shared/VBN
a/DT
known/JJ
relationship/NN
against/IN
BMI-related/JJ
diseases/NNS
,/,
such/JJ
as/IN
cardiovascular/JJ
disease/NN
,/,
body/NN
weight/NN
,/,
hypertension/NN
./.
====================
The/DT
main/JJ
purpose/NN
of/IN
a/DT
GWAS/JJ
is/VBZ
to/TO
detect/VB
genetic/JJ
variants/NNS
represented/VBN
by/IN
a/DT
single/JJ
SNP/NN
or/CC
a/DT
set/NN
of/IN
SNPs/NNS
that/DT
are/VBP
associated/VBN
with/IN
common/JJ
complex/NN
polygenic/JJ
traits/VBZ
of/IN
interest/NN
[/(
2/CD
,/,
4/CD
,/,
5/CD
,/,
16/CD
,/,
17/CD
]/)
./.
====================
However/RB
,/,
it/PRP
is/VBZ
commonly/RB
known/VBN
that/IN
multiple/JJ
genetic/JJ
factors/NNS
as/IN
well/RB
as/IN
several/JJ
environmental/JJ
factors/NNS
and/CC
their/PRP$
interactions/NNS
are/VBP
involved/VBN
in/IN
causing/VBG
complex/NN
diseases/NNS
./.
====================
Thus/RB
,/,
the/DT
single/JJ
SNP/NN
approach/NN
is/VBZ
not/RB
appropriate/JJ
for/IN
detecting/VBG
multiple/JJ
genetic/JJ
factors/NNS
for/IN
common/JJ
complex/NN
polygenic/JJ
traits/VBZ
./.
====================
Recently/RB
,/,
many/JJ
researchers/NNS
have/VBP
tried/VBN
GxG/NN
interaction/NN
analysis/NN
in/IN
GWASs/NNS
./.
====================
However/RB
,/,
they/PRP
focused/VBD
on/IN
rather/RB
restricted/JJ
regions/NNS
with/IN
a/DT
small/JJ
number/NN
of/IN
SNPs/NNS
due/JJ
to/TO
computational/JJ
complexity/NN
[/(
32/CD
,/,
33/CD
]/)
./.
====================
In/IN
this/DT
paper/NN
,/,
we/PRP
have/VBP
successfully/RB
performed/VBN
two-way/RB
GxG/NN
interaction/NN
analysis/NN
of/IN
8,838/CD
individuals/NNS
with/IN
the/DT
selected/VBN
101,837/CD
SNPs/NNS
,/,
which/WDT
cover/RB
most/JJS
genomic/JJ
regions/NNS
./.
====================
It/PRP
became/VBD
possible/JJ
with/IN
the/DT
help/NN
of/IN
a/DT
GPU-based/JJ
system/NN
with/IN
three/CD
GPU/NN
graphic/JJ
cards/NNS
./.
====================
It/PRP
took/VBD
only/RB
19/CD
h/NN
to/TO
perform/VB
51,853,363,660/CD
possible/JJ
two-way/NN
interaction/NN
analyses/NNS
with/IN
10-fold/JJ
cross-validation/NN
./.
====================
Our/PRP$
results/NNS
showed/VBD
that/IN
the/DT
FTO/NN
,/,
CBARA1/NN
,/,
CHUK/NN
,/,
SLIT3/NN
,/,
and/CC
NRXN3/NN
genes/NNS
are/VBP
strongly/RB
associated/VBN
with/IN
obesity/NN
./.
====================
In/IN
addition/NN
,/,
our/PRP$
approach/NN
provided/VBD
more/RBR
information/NN
about/IN
possible/JJ
GxG/NN
interactions/NNS
./.
====================
Note/RB
that/DT
some/DT
SNPs/NNS
having/VBG
weak/JJ
main/JJ
effects/NNS
showed/VBD
strong/JJ
interactions/NNS
with/IN
other/JJ
SNPs/NNS
(/(
Table/JJ
3/CD
)/)
./.
====================
It/PRP
would/MD
have/VBP
been/VBN
very/RB
difficult/JJ
to/TO
detect/VB
these/DT
SNPs/NNS
through/IN
single/JJ
SNP/NN
analysis/NN
,/,
which/WDT
demonstrates/VBZ
the/DT
usefulness/NN
of/IN
our/PRP$
approach/NN
in/IN
detecting/VBG
GxG/NN
interactions/NNS
./.
====================
In/IN
addition/NN
,/,
our/PRP$
analysis/NN
provided/VBD
some/DT
novel/JJ
interactions/NNS
that/WDT
have/VBP
not/RB
been/VBN
reported/VBN
in/IN
previous/JJ
studies/NNS
./.
====================
For/IN
example/NN
,/,
9/CD
SNPs/NNS
from/IN
the/DT
FTO/NN
gene/NN
were/VBD
found/VBN
to/TO
have/VB
interactions/NNS
with/IN
SNPs/NNS
from/IN
CNNM2/NN
,/,
AS3MT/NN
,/,
and/CC
NT5C2/NN
./.
====================
Similar/JJ
interactions/NNS
were/VBD
found/VBN
between/IN
LOC301738/NN
and/CC
PDZRN4/NN
,/,
as/IN
shown/VBN
in/IN
Fig/NN
./.
====================
1/CD
./.
====================
Our/PRP$
network/NN
graph/NN
summarizes/VBZ
two-way/NN
interactions/NNS
between/IN
SNPs/NNS
very/RB
efficiently/RB
./.
====================
We/PRP
expect/VBP
that/DT
this/DT
visualization/NN
tool/NN
could/MD
be/VB
helpful/JJ
to/TO
researchers/NNS
./.
====================
It/PRP
is/VBZ
also/RB
quite/RB
efficient/JJ
to/TO
identify/VB
specific/JJ
patterns/NNS
and/CC
hub/NN
genes/NNS
./.
====================
Through/IN
our/PRP$
network/NN
graph/NN
analysis/NN
,/,
we/PRP
also/RB
identified/VBD
several/JJ
pieces/NNS
of/IN
evidence/NN
that/IN
supported/VBD
the/DT
identified/VBN
interactions/NNS
with/IN
known/VBN
biological/JJ
information/NN
./.
====================
From/IN
the/DT
investigation/NN
with/IN
four/CD
published/VBN
databases/NNS
,/,
we/PRP
found/VBD
that/IN
39/CD
%/NN
of/IN
a/DT
total/JJ
of/IN
179/CD
interactions/NNS
with/IN
CVC/NN
=/JJ
10/CD
are/VBP
known/VBN
to/TO
have/VB
biological/JJ
interactions/NNS
from/IN
the/DT
four/CD
databases/NNS
we/PRP
collected/VBD
./.
====================
In/IN
addition/NN
,/,
our/PRP$
network/NN
graph/NN
analysis/NN
showed/VBD
a/DT
higher/JJR
identification/NN
rate/NN
of/IN
shared/JJ
biological/JJ
relevance/NN
when/WRB
the/DT
CVC/NN
was/VBD
large/JJ
than/IN
when/WRB
the/DT
CVC/NN
was/VBD
low/JJ
,/,
which/WDT
suggests/VBZ
that/IN
interactions/NNS
having/VBG
a/DT
high/JJ
value/NN
of/IN
CVC/NN
tend/CC
to/TO
share/VB
more/RBR
known/VBN
biological/JJ
evidence/NN
that/IN
are/VBP
actually/RB
related/JJ
the/DT
phenotype/NN
./.
====================
In/IN
summary/NN
,/,
our/PRP$
network/NN
graph/NN
analysis/NN
from/IN
GxG/NN
interaction/NN
analysis/NN
successfully/RB
identified/VBN
the/DT
relationship/NN
between/IN
interactions/NNS
from/IN
GMDR/NN
analysis/NN
and/CC
actual/JJ
biological/JJ
relevance/NN
./.
====================
In/IN
addition/NN
,/,
our/PRP$
strategy/NN
interpreted/JJ
GxG/NN
interactions/NNS
very/RB
effectively/RB
in/IN
finding/NN
known/VBN
biological/JJ
evidence/NN
using/VBG
multiple/JJ
public/JJ
databases/NNS
,/,
especially/RB
in/IN
finding/NN
evidence/NN
that/IN
is/VBZ
actually/RB
related/JJ
with/IN
the/DT
phenotype/NN
./.
====================
Visualized/VBN
result/NN
of/IN
significant/JJ
interactions/NNS
that/WDT
have/VBP
their/PRP$
cross-validation/NN
consistency/NN
≥9/CD
./.
====================
Arranged/VBN
for/IN
readability/NN
:/:
gray/JJ
background/NN
indicates/VBZ
hub/IN
node/NN
,/,
and/CC
red/JJ
,/,
white/JJ
,/,
blue/JJ
,/,
and/CC
yellow/RB
names/NNS
indicate/VBP
that/IN
they/PRP
are/VBP
identified/VBN
for/IN
their/PRP$
relation/NN
with/IN
obesity/NN
,/,
single-nucleotide/JJ
polymorphism/NN
,/,
gene/NN
,/,
and/CC
unidentified/JJ
gene/NN
locus/NN
,/,
respectively/RB
./.
====================
A/DT
visualization/NN
of/IN
gene-gene/NN
interaction/NN
interpretation/NN
with/IN
biological/JJ
knowledge/NN
./.
====================
Two/CD
red/JJ
circles/NNS
denote/VBP
two/CD
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
within/IN
a/DT
two-way/JJ
interaction/NN
,/,
and/CC
purple/JJ
circles/NNS
denote/VBP
corresponding/VBG
genes/NNS
against/IN
two/CD
SNPs/NNS
./.
====================
Gray/NN
circles/NNS
denote/VBP
diseases/NNS
that/WDT
are/VBP
known/VBN
to/TO
be/VB
related/JJ
with/IN
both/CC
of/IN
the/DT
genes/NNS
./.
====================
Yellow/RB
and/CC
orange/NN
circles/NNS
denote/VBP
a/DT
disrupted/JJ
transcriptional/JJ
factor/NN
by/IN
both/CC
of/IN
the/DT
two/CD
SNPs/NNS
and/CC
gene/NN
sets/NNS
including/VBG
genes/NNS
from/IN
both/CC
SNPs/NNS
,/,
respectively/RB
./.
====================
Top/RB
10/CD
SNPs/NNS
from/IN
linear/JJ
regression/NN
analysis/NN
====================
Result/NN
of/IN
two-way/JJ
interaction/NN
test/NN
====================
Single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
with/IN
weak/JJ
marginal/JJ
effect/NN
and/CC
strong/JJ
interaction/NN
====================
Short/NN
summary/NN
of/IN
biological/JJ
knowledge/NN
used/VBN
in/IN
this/DT
study/NN
====================
Proportion/NN
of/IN
known/VBN
biological/JJ
interactions/NNS
by/IN
cross-validation/NN
consistency/NN
(/(
CVC/NN
)/)
====================
